methylprednisolone and Acute-On-Chronic Liver Failure

methylprednisolone has been researched along with Acute-On-Chronic Liver Failure in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Duan, ZH; He, WP; Jia, L; Li, J; Liu, HX; Meng, QH; Ren, MX; Wang, XM; Xing, HC; Xue, R; Zhao, J; Zhu, Y1
Fan, YC; Fang, Y; Qian, Y; Wang, H; Wang, K; Wu, CS; Zhao, Q1
Hu, C; Lin, F; Ren, B; Shen, S; Zhang, A1

Other Studies

3 other study(ies) available for methylprednisolone and Acute-On-Chronic Liver Failure

ArticleYear
The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial.
    BMC medicine, 2020, 12-08, Volume: 18, Issue:1

    Topics: Acute-On-Chronic Liver Failure; Adult; Female; Hepatitis B virus; Humans; Male; Methylprednisolone; Middle Aged; Prognosis; Prospective Studies

2020
Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure.
    International journal of medical sciences, 2019, Volume: 16, Issue:3

    Topics: Acute-On-Chronic Liver Failure; Adult; Female; Gene Expression Regulation; Glucocorticoids; Hepatitis B, Chronic; Humans; Interleukin-18; Interleukin-1beta; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Prednisolone

2019
The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in rats.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:10

    Topics: Acute-On-Chronic Liver Failure; Animals; Anti-Inflammatory Agents; Biomarkers; Chemotherapy, Adjuvant; Disease Models, Animal; Female; Hepatectomy; Injections, Intravenous; Liver; Methylprednisolone; Portal Vein; Random Allocation; Rats; Rats, Wistar; Specific Pathogen-Free Organisms; Treatment Outcome

2014